Investors Look to Global Healthcare Market for Long-term Growth, Near-term Safe Haven, Says PwC
Healthcare was the third largest sector for global M&A activity in 2011, displacing finance in the top-three global middle market deal value rankings by Dealogic.
PwC highlights the following three key factors driving expected deal flow:
• Economic resilience, attractive demographic growth, and infrastructure build-out present a relatively safe investment for investors in a challenging macroeconomic environment.
• Within the sector, the declining value of incremental innovation implies a shift from investing in healthcare products such as drugs and medical devices towards technology and services.
• Innovative delivery models that offer better, cheaper, faster healthcare in countries such as Australia, India, and the Middle East are likely to attract new capital.
David Levy, MD, global healthcare leader, PwC, commented:
"Universal themes that drive healthcare markets globally -- healthcare reform, increasing competition from new market participants and the appetite for new, more efficient care delivery models -- has made M&A an increasingly important growth strategy for our healthcare clients. As healthcare becomes more globalised and investors broaden their geographic focus, PwC has professionals on the ground that can provide both context and connections."
According to Shelley Gnall, Global M&A Analyst, Healthcare, PwC:
"Despite today's challenging market conditions, the quest for growth continues. PwC's global newsletter launch seeks to provide broader market insights into transaction-related growth opportunities to our increasingly global clientele."
A full copy of the PwC Global Healthcare Deals Quarterly is available for download at http://www.pwc.com/healthcaredeals
About PwC Global Healthcare
PwC Global Healthcare works with leading healthcare providers, payers and health sciences organisations across the globe to provide business insights and real-time health solutions. PwC's global deals network includes 8,000 experienced professionals around the world. We advise corporate management teams, private equity funds, and the public sector, with a distinctive track record in healthcare midmarket transactions.
About the PwC network
PwC firms help organisations and individuals create the value they're looking for. We're a network of firms in 158 countries with close to 169,000 people who are committed to delivering quality in assurance, tax and advisory services. Tell us what matters to you and find out more by visiting us atwww.pwc.com.
"PwC" is the brand under which member firms of PricewaterhouseCoopers International Limited (PwCIL) operate and provide services. Together, these firms form the PwC network. Each firm in the network is a separate legal entity and does not act as agent of PwCIL or any other member firm. PwCIL does not provide any services to clients. PwCIL is not responsible or liable for the acts or omissions of any of its member firms nor can it control the exercise of their professional judgment or bind them in any way.
© 2012 PwC. All rights reserved.
PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.
Press Release and Documents
Christine WaltersGlobal Healthcare MarketingUnited Stateschristine.firstname.lastname@example.org+1 646 471 3359
More from News releases
Subscribe to rss feedXML
Most acquisitions and divestments don’t maximise value – even when some dealmakers think they do. But acquirers who prioritise value creation at the onset outperform peers by as much as 14%
Traditional cost-cutting measures aren’t enough to solve current profitability crisis in Financial Services industry
CEO confidence in growth dips dramatically